Medcomtech, S.A.
Symbol: MED.MC
EURONEXT
0.69
EURMarket price today
0.0000
P/E Ratio
0.0000
PEG Ratio
8.92M
MRK Cap
- 0.00%
DIV Yield
Medcomtech, S.A. (MED-MC) Stock Price & Analysis
Shares Outstanding
12.92M
Gross Profit Margin
0.67%
Operating Profit Margin
0.01%
Net Profit Margin
-0.03%
Return on Assets
-0.03%
Return on Equity
-0.42%
Return on Capital Employed
0.02%
Company general description and statistics
General Outlook
Return on Investments
Stock Prices
Liquidity Ratios
Analyzing MED.MC liquidity ratios reveals its financial health of the firm. The current ratio of 144.07% gauges short-term asset coverage for liabilities. The quick ratio (7.52%) assesses immediate liquidity, while the cash ratio (7.26%) indicates cash reserves.
cards.indicator | cards.value |
Current Ratio | 144.07% |
Quick Ratio | 7.52% |
Cash Ratio | 7.26% |
Profitability Ratios
MED.MC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -3.91% underscores its earnings before tax deductions. The effective tax rate stands at 11.05%, revealing its tax efficiency. The net income per EBT, 88.95%, and the EBT per EBIT, -315.79%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.24%, we grasp its operational profitability.
cards.indicator | cards.value |
Pretax Profit Margin | -3.91% |
Effective Tax Rate | 11.05% |
Net Income per EBT | 88.95% |
EBT per EBIT | -315.79% |
EBIT per Revenue | 1.24% |
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.44, it details the span from stock purchase to revenue.
cards.indicator | cards.value |
Days of Sales Outstanding | 8 |
Days of Inventory Outstanding | 361 |
Operating Cycle | 361.04 |
Days of Payables Outstanding | 432 |
Cash Conversion Cycle | -71 |
Payables Turnover | 0.84 |
Inventory Turnover | 1.01 |
Fixed Asset Turnover | 5.75 |
Asset Turnover | 0.81 |
Cash Flow Ratios
Lastly, the operating cash flow sales ratio, -0.09, offers insight into cash flow relative to sales.
cards.indicator | cards.value |
Operating Cash Flow Sales Ratio | -0.09 |
Free Cash Flow to Operating Cash Flow Ratio | 1.63 |
Cash Flow Coverage Ratio | -0.38 |
Short Term Coverage Ratio | -1.83 |
Capital Expenditure Coverage Ratio | -1.58 |
Dividend Paid and Capex Coverage Ratio | -1.58 |
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.53%, highlights its total liabilities relative to assets. With a debt-equity ratio of 5.05, we discern the balance between debt and equity financing. The long-term debt to capitalization, 79.95%, and total debt to capitalization, 83.48%, ratios shed light on its capital structure. An interest coverage of 0.27 indicates its ability to manage interest expenses.
cards.indicator | cards.value |
Debt Ratio | 18.53% |
Debt Equity Ratio | 5.05 |
Long Term Debt to Capitalization | 79.95% |
Total Debt to Capitalization | 83.48% |
Interest Coverage | 0.27 |
Cash Flow to Debt Ratio | -0.38 |
Company Equity Multiplier | 27.27 |
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.08%, indicates top-line expansion, while the gross profit growth, 24.56%, reveals profitability trends. EBIT growth, 57.23%, and operating income growth, 57.23%, offer insights into operational profitability progression. The net income growth, -13.29%, showcases bottom-line expansion, and the EPS growth, 100.00%, measures the growth in earnings per share.
cards.indicator | cards.value |
Revenue Growth | 11.08% |
Gross Profit Growth | 24.56% |
EBIT Growth | 57.23% |
Operating Income Growth | 57.23% |
Net Income Growth | -13.29% |
EPS Growth | 100.00% |
EPS Diluted Growth | 100.00% |
Weighted Average Shares Growth | -100.00% |
Weighted Average Shares Diluted Growth | -100.00% |
Operating Cash Flow Growth | -639.55% |
Free Cash Flow Growth | -55.39% |
10-Year Revenue Growth per Share | -100.00% |
5-Year Revenue Growth per Share | -100.00% |
3-Year Revenue Growth per Share | -100.00% |
10-Year Operating CF Growth per Share | -100.00% |
5-Year Operating CF Growth per Share | -100.00% |
3-Year Operating CF Growth per Share | 100.00% |
10-Year Net Income Growth per Share | -100.00% |
5-Year Net Income Growth per Share | 100.00% |
3-Year Net Income Growth per Share | -100.00% |
10-Year Shareholders Equity Growth per Share | -100.00% |
5-Year Shareholders Equity Growth per Share | -100.00% |
3-Year Shareholders Equity Growth per Share | -100.00% |
10-Year Dividend per Share Growth per Share | -100.00% |
Inventory Growth | 17.93% |
Asset Growth | 0.18% |
Book Value per Share Growth | -100.00% |
Debt Growth | -13.35% |
SGA Expenses Growth | 26.75% |
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,119,458, captures the company's total value, considering both debt and equity. Income quality, 1.19, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 0.90%, indicates the value of non-physical assets, and capex to operating cash flow, 63.26%, measures reinvestment capability.
cards.indicator | cards.value |
Enterprise Value | 4,119,458 |
Income Quality | 1.19 |
Sales General and Administrative to Revenue | 0.29 |
Intangibles to Total Assets | 0.90% |
Capex to Operating Cash Flow | 63.26% |
Capex to Revenue | -5.54% |
Capex to Depreciation | -123.11% |
Return on Tangible Assets | -2.85% |
Working Capital | 5,957,805 |
Tangible Asset Value | 733,394 |
Net Current Asset Value | -7,074,235 |
Invested Capital | 5 |
Average Payables | 9,578,647 |
Average Inventory | 6,832,825 |
Days Payables Outstanding | 432 |
Days of Inventory On Hand | 361 |
ROIC | 4.03% |
ROE | -0.77% |
Valuation Ratios
The price to sales ratio, 0.40, provides a perspective on valuation in relation to sales.
cards.indicator | cards.value |
Price to Sales Ratio | 0.40 |
Enterprise Value Multiple | 2.36 |
Price to Free Cash Flows Ratio | -2.78 |
Enterprise Value to Sales | 0.18 |
Enterprise Value Over EBITDA | 2.02 |
EV to Operating Cash Flow | -2.10 |
Frequently Asked Question
How many company shares are outstanding in 2024?
There are stock number shares outstanding of Medcomtech, S.A. (MED.MC) on the EURONEXT in 2024.
What is P/E ratio of enterprise in 2024?
The current P/E ratio of enterprise is 0.000 in 2024.
What is the ticker symbol of Medcomtech, S.A. stock?
The ticker symbol of Medcomtech, S.A. stock is MED.MC.
What is company IPO date?
IPO date of Medcomtech, S.A. is 2010-03-25.
What is company current share price?
Current share price is 0.690 EUR.
What is stock market cap today?
The market cap of stock today is 8915628.000.
What is PEG ratio in 2024?
The current 0.000 is 0.000 in 2024.
What is the number of employees in 2024?
In 2024 the company has 124.